lapatinib has been researched along with Status Epilepticus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Latif, NS; El-Kalaawy, AM; Lamie, PF; Philoppes, JN; Rashed, LA | 1 |
1 other study(ies) available for lapatinib and Status Epilepticus
| Article | Year |
|---|---|
Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Lithium Carbonate; Male; Mice; Molecular Structure; Pilocarpine; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptor, ErbB-2; Status Epilepticus; Structure-Activity Relationship | 2021 |